Experimental Ebola treatments begin in Congo as outbreak grows, offering hope to affected residents
By
Prosper Heri Ngorora, Mark Banchereau
Summary
Residents in eastern Congo's Ebola outbreak zone are hopeful as researchers launch a study of two experimental treatments at Bunia's Evangelical Medical Center. The outbreak, caused by the Bundibugyo virus, has infected over 1,400 people and killed 438. The trial, supported by WHO and involving Congo's national biomedical research institute and Oxford University, aims to enroll at least 500 patients. Challenges include community mistrust and overcrowded treatment centers.
Source
Key quotes
· 3 pulledResidents at the epicenter of Congo's Ebola outbreak are pinning their hopes on experimental treatments after researchers began a highly anticipated study in early July of two possible Ebola treatments in hopes of fighting the still-growing outbreak.
At the Ebola treatment center inside Bunia's Evangelical Medical Center, in eastern Congo's Ituri province, the launch of the research was marked by urgency rather than ceremony on Thursday.
As ambulances continued arriving and healthcare workers disappeared behind layers of protective equipment...
You might also wanna read

Residents in eastern Congo cling to hope as a new Ebola treatment trial begins
PARTNERS trial begins enrolling patients in DRC to test treatments for Bundibugyo virus disease
The PARTNERS clinical trial has begun enrolling patients in the Democratic Republic of the Congo to evaluate potential treatments for Bundib
PARTNERS trial begins enrolling patients in DRC to test treatments for Bundibugyo virus disease
The PARTNERS clinical trial has begun enrolling patients in the Democratic Republic of the Congo to evaluate potential treatments for Bundib

WHO declares international emergency over rare Ebola Bundibugyo outbreak in DRC and Uganda
The World Health Organization has declared a major outbreak of the rare Ebola Bundibugyo virus species an international emergency. Unlike th
U.S. Provides Experimental Ebola Drug for Clinical Trials in Congo Amid Worsening Outbreak
The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials to combat the worsening Ebola o

Understanding Ebola’s wildlife origins is crucial to preventing next big outbreak
Ebola Outbreak Worsens in Congo Amid Questions Over US Foreign Aid Cuts
The article examines the escalating Ebola outbreak in the Democratic Republic of Congo, which began in a mining village near the South Sudan

Comments
Sign in to join the conversation.
No comments yet. Be the first.